BLADDER SPARING TREATMENT IN PATIENTS WITH BCG UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER: AN ANALYSIS OF LONG-TERM SURVIVAL OUTCOMES

被引：0
|
作者：
Tan, Wei Shen
Grajales, Valentina
Contieri, Roberto
Hensley, Patrick
Bree, Kelly
Msaouel, Pavlos
Guo, Charles
Navai, Neema
Dinney, Colin
Kamat, Ashish
机构：
来源：
JOURNAL OF UROLOGY | 2023年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD13-12
引用
收藏
页码：E410 / E410
页数：1
相关论文
共 50 条
  • [31] LONG-TERM SURVIVAL OUTCOMES WITH INTRAVESICAL DOCETAXEL IN THE MANAGEMENT OF NON-MUSCLE-INVASIVE BLADDER CANCER (NMIBC) REFRACTORY TO BCG THERAPY
    Barlow, LaMont
    McKiernan, James
    Benson, Mitchell
    JOURNAL OF UROLOGY, 2012, 187 (04): : E677 - E677
  • [32] CG0070 for the treatment of non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG)
    Uchio, Edward M.
    Li, Roger
    Steinberg, Gary
    Lamm, Donald
    Kamat, Ashish
    Packiam, Vignesh
    Anderson, Paul
    Ku, Ja Hyeon
    Chisamore, Michael
    McAdory, John
    Hnat, Nataliya
    Kim, Jee-Hyun
    Grandi, Paola
    Burke, James
    CANCER SCIENCE, 2023, 114 : 1587 - 1587
  • [33] Long-Term Outcomes and Costs Among BCG-treated High-Risk Non-Muscle Invasive Bladder Cancer Patients in an Equal Access Setting
    Williams, S. B.
    Howard, L. E.
    Foster, M. L.
    Klaassen, Z.
    Li, H.
    Sieluk, J.
    Imai, K.
    Sbar, E., I
    De Hoedt, A. M.
    Freedland, S. J.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (12) : 902 - 902
  • [34] Long-term outcomes among BCG-treated high-risk non-muscle invasive bladder cancer patients in an equal access setting.
    Williams, Stephen B.
    Howard, Lauren
    Foster, Meagan
    Klaassen, Zachary William Abraham
    Sieluk, Jan
    Li, Haojie
    Imai, Kentaro
    Sbar, Eric
    De Hoedt, Amanda M.
    Freedland, Stephen J.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [35] COMPARISON OF REDUCED AND FULL BCG DOSING IN THE TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER
    Buck, Matthew
    Salib, Andrew
    Kloniecke, Edward
    Simhal, Rishabh
    Calvaresi, Anne
    Lallas, Costas
    Gomella, Leonard
    Izes, Joseph
    JOURNAL OF UROLOGY, 2023, 209 : E824 - E825
  • [36] Predictors of response to BCG therapy in non-muscle invasive bladder cancer
    Radovanovic, Milan
    Petrovic, Milos
    Santric, Veljko
    Zubelic, Aleksa
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2022, 150 (1-2) : 113 - 116
  • [37] CG0070 for the treatment of non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG)
    Li, R.
    Uchio, E.
    Steinberg, G. D.
    Shore, N.
    Anderson, P. D.
    Ben, T.
    Kamat, A.
    Keel, M.
    Packiam, V.
    McAdory, J.
    Kim, J. H.
    Chisamore, M.
    Grandi, P.
    Burke, J.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A130 - A130
  • [38] PHASE 3 STUDY OF VICINIUM IN BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER: INITIAL RESULTS
    Dickstein, Rian
    Wu, Ning
    Cowan, Barrett
    Dunshee, Curtis
    Franks, Michael
    Wolk, Fred
    Belkoff, Laurence
    Castelucci, Sean
    Holzbeierlein, Jeffrey
    Kulkarni, Girish
    Weizer, Alon
    Lamm, Donald
    Brooks, David
    Epstein, Jonathon
    Ali, Syed
    Kassouf, Wassim
    JOURNAL OF UROLOGY, 2018, 199 (04): : E1167 - E1167
  • [39] New Intravesical Agents for BCG-Unresponsive High-Risk Non-Muscle Invasive Bladder Cancer
    Asimakopoulos, Anastasios D.
    Kochergin, Maxim
    Colalillo, Gaia
    Fahmy, Omar
    Hassan, Fahmy
    Renninger, Markus
    Gallioli, Andrea
    Gavrilov, Pavel
    Gakis, Georgios
    BLADDER CANCER, 2023, 9 (03) : 237 - 251
  • [40] Real-world outcomes of Bladder Sparing Treatments (BSTs) in patients with highrisk non-muscle invasive bladder cancer, who failed or were intolerant to BCG therapy
    Day, E.
    Aquilina, R.
    Ta, A.
    Sridhar, A. N.
    Kelly, J. D.
    Szabados, B. E.
    EUROPEAN UROLOGY, 2024, 85 : S1180 - S1181
12345